Overview
Adult Krabbe disease (also known as adult-onset globoid cell leukodystrophy or adult-onset galactosylceramide lipidosis) is a rare, inherited lysosomal storage disorder caused by deficiency of the enzyme galactosylceramidase (GALC). This enzyme is essential for the breakdown of galactosylceramide and psychosine, which are key components of myelin in the nervous system. When GALC is deficient, these toxic substrates accumulate, leading to progressive destruction of myelin-producing cells (oligodendrocytes in the central nervous system and Schwann cells in the peripheral nervous system). Adult Krabbe disease is the latest-onset form of the condition, typically presenting after age 16 and sometimes not until the third or fourth decade of life. The disease primarily affects the central and peripheral nervous systems. Key clinical features include progressive spastic paraparesis (stiffness and weakness of the legs), peripheral neuropathy, cerebellar ataxia, visual impairment, and cognitive decline. Unlike the rapidly fatal infantile form, adult-onset Krabbe disease tends to progress more slowly, and cognitive function may be relatively preserved early in the course. Some patients present predominantly with motor symptoms such as gait difficulties and spasticity, while others may develop burning paresthesias or loss of fine motor skills. Brain MRI typically shows white matter abnormalities, and nerve conduction studies often reveal a demyelinating peripheral neuropathy. There is currently no cure for adult Krabbe disease. Treatment is primarily supportive and symptomatic, including physical therapy, management of spasticity, and pain control. Hematopoietic stem cell transplantation (HSCT) has shown benefit in presymptomatic or early-symptomatic infantile cases, and it has been explored in adult-onset patients, though evidence for its efficacy in this population remains limited. Enzyme replacement therapy and gene therapy approaches are under investigation. The disease is caused by pathogenic variants in the GALC gene located on chromosome 14q31.
Clinical phenotype terms— hover any for plain English:
Autosomal recessive
Passed on when both parents carry the same gene change; often skips generations
Adult
Begins in adulthood (age 18 or older)
Treatments
No FDA-approved treatments are currently listed for Adult Krabbe disease.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Adult Krabbe disease at this time.
New trials open frequently. Follow this disease to get notified.
Rare Disease Specialist
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Adult Krabbe disease.
Community
No community posts yet. Be the first to share your experience with Adult Krabbe disease.
Start the conversation →Latest news about Adult Krabbe disease
No recent news articles for Adult Krabbe disease.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Adult Krabbe disease
What is Adult Krabbe disease?
Adult Krabbe disease (also known as adult-onset globoid cell leukodystrophy or adult-onset galactosylceramide lipidosis) is a rare, inherited lysosomal storage disorder caused by deficiency of the enzyme galactosylceramidase (GALC). This enzyme is essential for the breakdown of galactosylceramide and psychosine, which are key components of myelin in the nervous system. When GALC is deficient, these toxic substrates accumulate, leading to progressive destruction of myelin-producing cells (oligodendrocytes in the central nervous system and Schwann cells in the peripheral nervous system). Adult K
How is Adult Krabbe disease inherited?
Adult Krabbe disease follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Adult Krabbe disease typically begin?
Typical onset of Adult Krabbe disease is adult. Age of onset can vary across affected individuals.
Which specialists treat Adult Krabbe disease?
1 specialists and care centers treating Adult Krabbe disease are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.